Netflix Quote - NFLX34 | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Brazil
BOV
Netflix Inc. (NFLX34) Share Price

Netflix Inc. (NFLX34)

112.32

-1.50

(-1.32%)

Closed December 17 2:55PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

112.60

Bid

111.46

Ask

113.48

Volume

30,870

111.70 Day's Range 114.84

45.44 52 Week Range 114.84

Market Cap

Previous Close

113.82

Open

113.01

Last Trade

Last Trade Time

Financial Volume

R$ 3,494,361

VWAP

113.196

Average Volume (3m)

49,219

Shares Outstanding

416,681,000

Dividend Yield

-

PE Ratio

70.82

Earnings Per Share (EPS)

12.98

Revenue

33.72B

Net Profit

5.41B

Sector

Video Tape Rental

Industry

Video Tape Rental

Website

www.netflix.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Netflix Inc. is listed in the Video Tape Rental sector of the Brazil Bovespa Exchange with ticker NFLX34. The last closing price for Netflix was R$113.82. Over the last year, Netflix shares have traded in a share price range of R$ 45.44 to R$ 114.84.

Netflix currently has 416,681,000 shares outstanding. The market capitalization of Netflix is R$47.43 billion. Netflix has a price to earnings ratio (PE ratio) of 70.82.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.7	0.625558534406	111.9	114.84	109.87	41573	112.56828889	DR
4	15.49	15.9509834209	97.11	114.84	96.28	46571	107.91627695	DR
12	35.09	45.2715778609	77.51	114.84	75.92	49219	93.21992398	DR
26	40.3	55.7399723375	72.3	114.84	67.91	50214	82.35549547	DR
52	66.1	142.150537634	46.5	114.84	45.44	49826	71.07754496	DR
156	45.54	67.9093349239	67.06	114.84	16.84	216546	32.26068638	DR
260	86.50452306	331.492400997	26.09547694	114.84	0.0408	145422	35.15346594	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ATED3Atom Educacao E Editora S.A.	R$ 2.05 (39.46%)	267.1k
AGXY3Agrogalaxy Participacoes SA	R$ 0.50 (25.00%)	4.74M
DOTZ3Dotz S.A.	R$ 3.20 (18.96%)	68.4k
DASA11Diagnosticos da America S.A	R$ 1.08 (13.68%)	100
IFCM3Infracommerce Caxaas S.A.	R$ 0.09 (12.50%)	9.38M
COCE11Cia Energetica Ceara Coelce	R$ 0.39 (-35.00%)	11.7k
CRPG3TronoxPigmentos do Brasil S.A.	R$ 21.15 (-20.19%)	1.5k
QUAL3Qualicorp Consultoria e Corretora de Seguros S.A.	R$ 1.79 (-17.51%)	11.66M
EPAR3Embpar Participacoes S.A.	R$ 5.65 (-15.67%)	44.5k
AZEV3Azevedo Travassos Sa	R$ 1.07 (-13.71%)	1.29M
HAPV3Hapvida Participacoes Investimento SA	R$ 2.28 (-11.28%)	313.56M
COGN3CognaEducacao SA	R$ 1.09 (1.87%)	80.64M
BBDC4Bco Bradesco Sa	R$ 11.99 (0.756303%)	66.96M
ITSA4Itausa Investimentos Itau SA	R$ 9.04 (0.110742%)	52.07M
ITUB4Itau Unibanco Holding SA	R$ 31.88 (0.536108%)	40.11M

JMoneyHoops

JMoneyHoops 2 minutes ago

Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

dstock07734

dstock07734 2 minutes ago

KILLAZILLA

KILLAZILLA 3 minutes ago

DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......

gitreal

gitreal 3 minutes ago

...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i

flipper44

flipper44 4 minutes ago

Those people know we can still see them, right?

awesomed007

awesomed007 4 minutes ago

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

awesomed007

awesomed007 4 minutes ago

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

Eatatjoes

Eatatjoes 4 minutes ago

Paul Malec of Deer Park, NY

fuagf

fuagf 4 minutes ago

Yeps, yeps and yeps. Good ones.

NoMoDo

NoMoDo 5 minutes ago

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.

manibiotech

manibiotech 5 minutes ago

Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you

1vman

1vman 5 minutes ago

*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔

janice shell

janice shell 6 minutes ago

First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so

HappyAlways

HappyAlways 7 minutes ago

I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t

TheDane

TheDane 7 minutes ago

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 7 minutes ago

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 8 minutes ago

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 9 minutes ago

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 10 minutes ago

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 11 minutes ago

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 12 minutes ago

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 12 minutes ago

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 12 minutes ago

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 12 minutes ago

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

NASDAQ Biotechnology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions